Login to Your Account



Clinic Roundup


Friday, September 20, 2013
• Oncomed Pharmaceuticals Inc., of Redwood City, Calif., said it started a Phase Ib/II trial of cancer stem cell candidate demcizumab (OMP-21M18) in ovarian cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription